Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report on the market for cardiovascular drugs. The report shows that the market for cardiovascular patients will increase to 251 million in three years with the greatest rate of growth forecast for the US market.
“Cardiovascular Pharmaceutical Market Trends 2007 to 2010 - Key Market Forecasts and Growth Opportunities”
The slow-down in cardiovascular market growth between 2003 and 2005 is forecast to continue through to 2010. While continued changes in demographics and lifestyle will continue to drive cardiovascular sales forward, growth rates will be limited by continued patent expiries for major products and a dearth of novel therapies being introduced.
The study shows that the anti-hypertensives drug class dominates the global cardiovascular market with a market share of nearly 50%. Also, of the top 20 products by global cardiovascular sales in 2005, all 20 generated annual sales in excess of US$1 billion.
The findings also include that a total of 14 pharmaceutical companies were identified as having generated cardiovascular sales in excess of US$1 billion in 2005.
The report provides an excellent overview to the current and future market dynamics and size for drug treatments for cardiovascular-
“Cardiovascular Pharmaceutical Market Trends 2007 to 2010” is available in from Report Buyer. For more information, go to: http://www.reportbuyer.com/
Report Buyer ID: URC00021
